Skip to content
StockMarketAgent
Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

ETR/GXE stock hub

ETR/GXE has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

ETR/GXEis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
1.6B
Deutsche Börse Xetra
Market data

Live price

Current market quote for this ticker.

Current price
ETR/GXE
In the news

Latest news · ETR/GXE

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/E3.2
P25 n/aP50 n/aP75 n/a
ROE16.3
P25 n/aP50 n/aP75 n/a
ROIC241.3
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All ETR/GXE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
175
Groups with data
11
Currency
EUR
Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

16
MetricValue
Country
Belgium
Country code
DE
Employees
704
Enterprise value
EUR -1.4B
Exchange
Deutsche Börse Xetra
Financial currency
EUR
First seen
2026-05-10
Industry
Biological Products, Except Diagnostic Substances
Last refreshed
2026-05-10
Market cap
EUR 1.6B
Price
EUR 24.02
Price currency
EUR
Rev Per Employee
1,482,602.27x
Sic
2836
Symbol
etr/GXE
Website
https://www.glpg.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
30.88%
EV Earnings
-2.85x
EV/FCF
4.49x
FCF yield
-19.61%
P/B ratio
0.49x
P/E ratio
3.24x
P/S ratio
1.52x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

15
MetricValue
EBIT Margin
60.39%
EBITDA Margin
63.52%
Gross margin
53.99%
Gross Profit
EUR 563.5M
Gross Profit Growth Q
-97.25%
Net Income
EUR 488.8M
Pretax Margin
45.14%
Profit Margin
46.83%
Profit Per Employee
EUR 694,288
ROA
10.65
Roa5y
0.27
ROCE
19.26
ROE
16.26
Roe5y
0.58
ROIC
241.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

10
MetricValue
Cagr10y
-5.01%
Cagr15y
6.25%
Cagr1y
5.54%
Cagr20y
4.83%
Cagr3y
-14.51%
Cagr5y
-17.74%
Revenue Growth
262.17x
Revenue Growth Q
-91.36x
Revenue Growth3 Y
85.52x
Revenue Growth5 Y
16.4x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

21
MetricValue
Asset Turnover
EUR 0.28
Assets
EUR 3.4B
Cash
EUR 3B
Current Assets
EUR 3.1B
Current Liabilities
EUR 100.4M
Debt
EUR 6.4M
Debt EBITDA
EUR 0.01
Debt Equity
EUR 0
Debt FCF
EUR -0.02
Equity
EUR 3.3B
Interest Coverage
1,612
Liabilities
EUR 119.1M
Long Term Assets
EUR 311.7M
Long Term Liabilities
EUR 18.6M
Net Cash
EUR 3B
Net Cash By Market Cap
EUR 188
Net Cash Growth
-9.45%
Net Debt EBITDA
EUR -4.49
Net Debt Equity
EUR -0.91
Tangible Book Value
EUR 3.3B
Tangible Book Value Per Share
EUR 49.38

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
30.48
Inventory Turnover
17.09
Net Working Capital
EUR -20.3M
Quick ratio
30.23
Working Capital
EUR 3B
Working Capital Turnover
EUR 0.35

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-0.03%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
10Y total return
-40.19%
1Y total return
5.54%
200-day SMA
27.25
3Y total return
-37.53%
50-day SMA
25.94
50-day SMA vs 200-day SMA
50under200
5Y total return
-62.33%
All Time High
251
All Time High Change
-90.43%
All Time High Date
2020-02-20
All Time Low
2.82
All Time Low Change
751.77%
All Time Low Date
2008-10-28
ATR
0.41
Ch YTD
-13.97
High
24.64
High52
31.86
High52 Date
2025-10-06
High52ch
-25.5%
Low
23.86
Low52
22.34
Low52 Date
2025-05-09
Low52ch
2.13%
Ma50ch
-7.39%
Price vs 200-day SMA
-11.85%
RSI
39.33
RSI Monthly
39.74
RSI Weekly
32.65
Sharpe ratio
0.23x
Sortino ratio
0.49
Total Return
-0.03%
Tr YTD
-13.97
Tr15y
148.14%
Tr1m
-2.99%
Tr1w
0.17%
Tr3m
-14.03%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
EUR 630.3M
Operating margin
60.39

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

4
MetricValue
Float
44,538,448%
Net Borrowing
-2,772,000
Shares Qo Q
-0.07%
Shares Yo Y
0.03%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

57
MetricValue
Adjusted FCF
EUR -334.3M
Average Volume
7x
Bv Per Share
49.39
CAPEX
EUR -8.7M
Ch10y
-40.19
Ch15y
148.1
Ch1m
-2.99
Ch1w
0.17
Ch1y
5.54
Ch20y
156.6
Ch3m
-14.03
Ch3y
-37.53
Ch5y
-62.33
Ch6m
-10.71
Change
-2.28%
Change From Open
-2.44
Close
24.58
Days Gap
0.16
Depreciation Amortization
32,673,500
Dollar Volume
57,287.7
Earnings Date
2026-05-06
EBIT
EUR 630.3M
EBITDA
EUR 663M
EPS
EUR 7.42
F Score
5
FCF
EUR -310.3M
FCF EV Yield
22.28x
Financing CF
-2,772,000
Fiscal Year End
December
Founded
1,999
Graham Number
90.7712
Graham Upside
277.9
Income Tax
EUR -16.7M
Investing CF
265,566,000
Is Primary Listing
0
Last Earnings Date
2026-05-06
Last Report Date
2026-03-31
Ma150
27.15
Ma150ch
-11.51%
Ma20
24.24
Ma20ch
-0.9%
Net CF
-41,262,000
Next Earnings Date
2026-08-10
Open
24.62
Position In Range
20.51
Ppne
76,950,000
Price Date
2026-05-07
Price EBITDA
EUR 2.39
Ptbv Ratio
0.49
Relative Volume
6.06x
Revenue
1,043,752,000x
SBC By Revenue
2.3x
Share Based Comp
23,999,000
Tax By Revenue
-1.6x
Tr20y
156.62%
Tr6m
-10.71%
Volume
2,385
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does ETR/GXE pay a dividend?

Capital-return profile for this ticker.

Performance

ETR/GXE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+5.5%
S&P 500 1Y: n/a
3Y total return
-37.5%
S&P 500 3Y: n/a
5Y total return
-62.3%
S&P 500 5Y: n/a
10Y total return
-40.2%
S&P 500 10Y: n/a
Ownership

Who owns ETR/GXE?

Insider, institutional, and short-interest positioning.

Institutional ownership
n/a
Share of float held by funds and institutions
Insider ownership
n/a
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.0%
Negative means the company is buying back shares.
Technical

ETR/GXE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
39.3
Neutral momentum band
Price vs 200-day MA
-11.8%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.23
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About ETR/GXE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/GXE stock rating?

etr/GXE is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/GXE analysis?

The full report lives at /stocks/etr/GXE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/GXE?

The latest report frames etr/GXE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/GXE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

etr/GXE stock profile: metrics, valuation and analysis | وكيل سوق الأسهم بالذكاء الاصطناعي